• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-K filed by Cibus Inc.

    9/16/25 4:07:49 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials
    Get the next $CBUS alert in real time by email
    8-K
    false 0001705843 0001705843 2025-09-16 2025-09-16
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): September 16, 2025

     

     

    Cibus, Inc.

    (Exact name of registrant as specified in its charter)

     

     

     

    Delaware   001-38161   27-1967997

    (State or other jurisdiction

    of incorporation)

     

    (Commission

    File Number)

     

    (IRS Employer

    Identification No.)

     

    6455 Nancy Ridge Drive

    San Diego, CA

      92121
    (Address of principal executive offices)   (Zip Code)

    Registrant’s telephone number, including area code: (858) 450-0008

    Not Applicable

    (Former name or former address, if changed since last report.)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading
    Symbol(s)

     

    Name of exchange

    on which registered

    Class A Common Stock, $0.0001 par value per share   CBUS   The Nasdaq Stock Market LLC

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     
     


    Item 5.02.

    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

    On September 11, 2025, the board of directors (the “Board”) of Cibus, Inc. (the “Company”) appointed Kimberly A. Box to serve as member of the Board, effective as of such date. Ms. Box will serve as a member of the Board’s standing Compensation Committee and standing Nominating and Corporate Governance Committee as well as a member of the special committee of the Board that is evaluating strategic alternatives to maximize shareholder value, in each case, effective as of such date.

    Ms. Box, 65, Ms. Box previously served as the President and Chief Executive Officer of Gatekeeper Innovation, Inc. (acquired by RxGuardian), a healthcare company that creates products to keep medications safe, which she joined in 2016. Prior to joining Gatekeeper Innovation, Ms. Box enjoyed a successful 29-year career with Hewlett Packard (NYSE: HPQ), holding various executive positions, the most recent being Vice President, Global IT Services, a position she held until 2009 when she left Hewlett Packard. Ms. Box also serves on the Boards of Directors of McGrath RentCorp (NASDAQ: MGRC), where she serves as Chair of the Compensation Committee and is a member of the Audit Committee and Corporate Governance and Nominating Committee, and Applied Science, Inc. (“ASI”), a private company. Ms. Box formerly served on the Board of Directors of American River Bank (NASDAQ: AMRB) until it was acquired in 2021. Ms. Box holds a Bachelor of Science in Business Administration with a concentration in Management and a minor in Computer Science from California State University, Chico. She also completed the Executive Development Program at The Wharton School of the University of Pennsylvania and has a NACD Directorship Certification™ (2021) and a CERT in Cybersecurity Oversight from the Software Engineering Institute at Carnegie Mellon University (2022). Ms. Box was formerly on the NACD Northern California Chapter board and served as the Chair, and was named to the NACD Directorship 100™, an annual recognition of the leading corporate directors who significantly impact boardroom practices and performance.

    There are no arrangements or understandings between Ms. Box and any other persons pursuant to which Ms. Box was named as a director of the Board. Ms. Box has no direct or indirect material interest in any transaction or proposed transaction required to be reported under Item 404(a) of Regulation S-K.

    In accordance with the Company’s customary practice, the Company entered into its standard form of indemnification agreement for directors and executive officers with Ms. Box in connection with her election to the Board. Pursuant to the Company’s Non-Employee Director Compensation Policy, the Board agreed to provide Ms. Box with annual compensation comprising (i) a cash retainer equal to $60,000, payable semi-annually, and (ii) subject to board approval and granting pursuant to the terms and provisions of the Cibus, Inc. 2017 Omnibus Incentive Plan, as amended, equity compensation with a grant date value equal to $90,000. Such annual compensation will be prorated for Ms. Box’s service for the remainder of the 2025 fiscal year.


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, Cibus, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    Dated: September 16, 2025

     

    CIBUS, INC.
    By:  

    /s/ Peter Beetham

    Name:   Peter Beetham, Ph.D.
    Title:   Interim Chief Executive Officer
    Get the next $CBUS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CBUS

    DatePrice TargetRatingAnalyst
    7/29/2024$25.00Buy
    Alliance Global Partners
    7/19/2024$22.00Buy
    Canaccord Genuity
    10/9/2023$25.00Buy
    H.C. Wainwright
    7/19/2023$30.00Buy
    Canaccord Genuity
    More analyst ratings

    $CBUS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Box Kimberly Ann

    4 - Cibus, Inc. (0001705843) (Issuer)

    9/26/25 9:30:15 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    New insider Box Kimberly Ann claimed no ownership of stock in the company (SEC Form 3)

    3 - Cibus, Inc. (0001705843) (Issuer)

    9/26/25 9:24:34 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Director Riggs Rory B exercised 4,050,000 in-the-money shares at a strike of $0.00, increasing direct ownership by 38% to 14,583,307 units (SEC Form 4)

    4 - Cibus, Inc. (0001705843) (Issuer)

    6/11/25 5:11:05 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    $CBUS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cibus Announces the Election of Kimberly A. Box to Board of Directors

    SAN DIEGO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ: CBUS), a leading agricultural technology company developing and licensing advanced plant traits that enable higher yields, lower input costs, and more sustainable farming, today announced the election of Kimberly A. Box to its Board of Directors. "Kim brings to Cibus extensive leadership experience in technology and commercialization that will be invaluable as we sharpen our strategic commercialization efforts," said Mark Finn, Cibus Chairman. "Her understanding of market dynamics and experience in guiding innovation into scalable businesses will strengthen our strategic governance as we continue to drive long-term value c

    9/25/25 4:05:00 PM ET
    $CBUS
    $MGRC
    Agricultural Chemicals
    Industrials
    Diversified Commercial Services
    Consumer Discretionary

    Cibus CEO to Highlight Gene Editing's Role in Building Resilient Agriculture at UN Climate Week 2025

    SAN DIEGO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company specializing in the development and licensing of gene-edited plant traits, today announced that Peter Beetham, Co-Founder, President, and Interim Chief Executive Officer, will participate in a featured panel during UN Climate Week 2025 in New York City. The event, titled "Investing in a Resilient Future: Innovation, Data & Capital for Energy, Food, Water, and Climate Solutions", supported by Syntax Data, will be held on Tuesday, September 23rd at Midtown Loft, New York City, with a livestream available via LinkedIn. Dr. Beetham will join leaders from the United Nations Devel

    9/22/25 12:10:00 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Cibus Enters into Agreement with the Latin American Rice Hybrid Consortium to Provide Cibus' Herbicide Tolerance Trait

    Cibus and Centro Internacional de Agricultura Tropical (CIAT) have entered into an agreement to introduce Cibus' proprietary herbicide tolerance trait into elite rice germplasm for Latin America Agreement represents another significant milestone as Cibus aims to bring Latin America rice growers new solutions for advanced weed management in Rice crops SAN DIEGO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company specializing in the development and licensing of gene-edited plant traits, today announced a material transfer agreement with Centro Internacional de Agricultura Tropical (CIAT), an organization which, in collaboration with the L

    8/28/25 7:00:00 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    $CBUS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $CBUS
    SEC Filings

    View All

    Alliance Global Partners initiated coverage on Cibus Global with a new price target

    Alliance Global Partners initiated coverage of Cibus Global with a rating of Buy and set a new price target of $25.00

    7/29/24 7:49:52 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Canaccord Genuity resumed coverage on Cibus Global with a new price target

    Canaccord Genuity resumed coverage of Cibus Global with a rating of Buy and set a new price target of $22.00

    7/19/24 8:34:00 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    H.C. Wainwright initiated coverage on Cibus Global with a new price target

    H.C. Wainwright initiated coverage of Cibus Global with a rating of Buy and set a new price target of $25.00

    10/9/23 8:32:05 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    SEC Form 8-K filed by Cibus Inc.

    8-K - Cibus, Inc. (0001705843) (Filer)

    9/23/25 4:17:55 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    SEC Form 8-K filed by Cibus Inc.

    8-K - Cibus, Inc. (0001705843) (Filer)

    9/16/25 4:07:49 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by Cibus Inc.

    SCHEDULE 13G/A - Cibus, Inc. (0001705843) (Subject)

    8/14/25 8:59:40 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    $CBUS
    Leadership Updates

    Live Leadership Updates

    View All

    Cibus Announces the Election of Kimberly A. Box to Board of Directors

    SAN DIEGO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ: CBUS), a leading agricultural technology company developing and licensing advanced plant traits that enable higher yields, lower input costs, and more sustainable farming, today announced the election of Kimberly A. Box to its Board of Directors. "Kim brings to Cibus extensive leadership experience in technology and commercialization that will be invaluable as we sharpen our strategic commercialization efforts," said Mark Finn, Cibus Chairman. "Her understanding of market dynamics and experience in guiding innovation into scalable businesses will strengthen our strategic governance as we continue to drive long-term value c

    9/25/25 4:05:00 PM ET
    $CBUS
    $MGRC
    Agricultural Chemicals
    Industrials
    Diversified Commercial Services
    Consumer Discretionary

    Cibus CEO to Highlight Gene Editing's Role in Building Resilient Agriculture at UN Climate Week 2025

    SAN DIEGO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company specializing in the development and licensing of gene-edited plant traits, today announced that Peter Beetham, Co-Founder, President, and Interim Chief Executive Officer, will participate in a featured panel during UN Climate Week 2025 in New York City. The event, titled "Investing in a Resilient Future: Innovation, Data & Capital for Energy, Food, Water, and Climate Solutions", supported by Syntax Data, will be held on Tuesday, September 23rd at Midtown Loft, New York City, with a livestream available via LinkedIn. Dr. Beetham will join leaders from the United Nations Devel

    9/22/25 12:10:00 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Totus Medicines Appoints Simon Harnest, MSc, BSc, as Chief Financial Officer

    EMERYVILLE, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Totus Medicines, a company revolutionizing small molecule drug discovery and development using covalent DNA-encoded libraries and AI tools, today announced the appointment of Simon Harnest, MSc, BSc, as Chief Financial Officer. This key addition comes at a pivotal moment for Totus as the company prepares to advance its clinical-stage program following encouraging results from its Phase 1 study of TOS-358, a covalent PI3Kα inhibitor. "The addition of Simon, with over 15 years' experience in private capital markets strategy and IPO processes, comes at the right time for Totus as we advance our clinical-stage and discovery programs," said

    1/28/25 8:00:00 AM ET
    $CBUS
    $CLLS
    $MGX
    Agricultural Chemicals
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CBUS
    Financials

    Live finance-specific insights

    View All

    Cibus to Report Second Quarter 2025 Financial Results on August 14, 2025 After the Market Close and Host Conference Call

    SAN DIEGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that the company will report second quarter 2025 financial results on Thursday, August 14, 2025. Cibus' management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. Title: Cibus, Inc. Second Quarter 2025 Results Conference Call Event Date: Thursday, August 14, 2025Time: 4:30 p.m. ETParticipant Numbers: +1-833-316-2483 (U.S.), +1-785-838-9284 (International)The conference ID "CIBUS" or 24287 will be required for en

    8/5/25 7:00:00 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Cibus Reports First Quarter Financial Results and Provides Year-to-Date Business Update for 2025

    Rice business momentum builds with Cibus' first stacked gene edited herbicide tolerance traits, which the Company believes is an industry first; On track for 2027 targeted commercial launch of HT1 and HT3 traits with customer germplasm integration underway across multiple markets Positive regulatory decision for Cibus' Rice traits HT1 and HT3 in Ecuador; the Ministry of Agriculture and Livestock in Ecuador determined that the Company's HT1 and HT3 Rice traits are equivalent to those developed through conventional breeding Disease resistance program advances with positive Sclerotinia data for multiple modes of action against Sclerotinia in Canola; Cibus' time bound and predictable RTDS tech

    5/8/25 4:05:00 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Cibus to Report First Quarter 2025 Financial Results on May 8, 2025 After the Market Close and Host Conference Call

    SAN DIEGO, April 25, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that the company will report first quarter 2025 financial results on Thursday, May 8, 2025. Cibus' management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. Title: Cibus, Inc. First Quarter 2025 Results Conference Call Event Date: Thursday, May 8, 2025Time: 4:30 p.m. ETParticipant Numbers: +1-833-316-1983 (U.S.), +1-785-838-9310 (International)The c

    4/25/25 7:00:00 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials